AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $170,826,000 | +28.4% | 174,372,000 | +10.8% | 3.40% | +23.9% |
| Q2 2022 | $133,036,000 | -6.2% | 157,390,000 | 0.0% | 2.74% | -13.5% |
| Q1 2022 | $141,877,000 | +9.0% | 157,390,000 | 0.0% | 3.17% | +16.2% |
| Q4 2021 | $130,154,000 | -9.5% | 157,390,000 | 0.0% | 2.73% | -2.7% |
| Q3 2021 | $143,842,000 | -8.2% | 157,390,000 | 0.0% | 2.81% | +0.9% |
| Q2 2021 | $156,612,000 | +1.4% | 157,390,000 | +5.2% | 2.78% | -14.3% |
| Q1 2021 | $154,446,000 | +12.7% | 149,600,000 | 0.0% | 3.25% | +19.8% |
| Q4 2020 | $137,072,000 | +14.1% | 149,600,000 | 0.0% | 2.71% | -7.4% |
| Q3 2020 | $120,099,000 | – | 149,600,000 | – | 2.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,100,000 | $8,937,000 | 3.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 174,372,000 | $170,826,000 | 3.40% |
| PFM Health Sciences, LP | 48,150,000 | $47,381,000 | 1.71% |
| DeepCurrents Investment Group LLC | 17,738,000 | $17,424,000 | 0.67% |
| Weiss Asset Management LP | 17,595,000 | $17,263,000 | 0.42% |
| DAFNA Capital Management LLC | 1,500,000 | $1,476,000 | 0.40% |
| Westchester Capital Management, LLC | 3,853,000 | $3,792,000 | 0.11% |
| Calamos Advisors LLC | 15,438,000 | $15,147,000 | 0.07% |
| Verition Fund Management LLC | 10,316,000 | $5,081,076 | 0.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,532,000 | $2,491,000 | 0.03% |